ScholarIQanswers from OpenAlex & ORCID
Anthony Rosenzweig
ResearcherPublications, citations & collaboration network
Anthony Rosenzweig is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Anthony Rosenzweig have?
ScholarIQindexed works
Anthony Rosenzweig has 315 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Anthony Rosenzweig have?
ScholarIQcitation count
Anthony Rosenzweig has 27,465 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Anthony Rosenzweig?
ScholarIQh-index
Anthony Rosenzweig has an h-index of 83 in OpenAlex.
What is the i10-index of Anthony Rosenzweig?
ScholarIQi10-index
Anthony Rosenzweig has an i10-index of 176 in OpenAlex.
What is the ORCID of Anthony Rosenzweig?
ScholarIQorcid
The ORCID for Anthony Rosenzweig is on the source record.
What is the OpenAlex record for Anthony Rosenzweig?
ScholarIQopenalex
The OpenAlex for Anthony Rosenzweig is on the source record.
What are the most-cited papers on Anthony Rosenzweig?
ScholarIQmost cited works
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkelä, Luanda Grazette, Rinat Yacobi, Cezar Iliescu, Richard D. Patten, Cara Beahm, Brian Walters, Sergei Shevtsov, Stéphanie Pesant, Fred J. Clubb, Anthony Rosenzweig, Robert Salomon, Richard A. Van Etten, Joseph Alroy, Jean‐Bernard Durand, Thomas Force
Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart
Takashi Matsui, Ling Li, Justina Wu, Stuart A. Cook, Tomohisa Nagoshi, Michael H. Picard, Ronglih Liao, Anthony Rosenzweig
Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury
Ryuji Hataishi, Ana Clara Tude Rodrigues, Tomas G. Neilan, John G. Morgan, Emmanuel S. Buys, Sruti Shiva, Rosemary Tambouret, Davinder S. Jassal, Michael J. Raher, Elissa Furutani, Fumito Ichinose, Mark T. Gladwin, Anthony Rosenzweig, Warren M. Zapol, Michael H. Picard, Kenneth D. Bloch, Marielle Scherrer‐Crosbie
Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Enchi Liu, Mark E. Schmidt, Richard Margolin, Reisa A. Sperling, Robert A. Koeppe, N. Scott Mason, William E. Klunk, Chester A. Mathis, Stephen Salloway, Nick C. Fox, David Hill, Andrea S. Les, Peter Collins, Keith M. Gregg, Jianing Di, Yuan Lü, Iulia Cristina Tudor, Bradley T. Wyman, Kevin Booth, S Broome, Eric Yuen, Michael Grundman, H. Robert Brashear, Stephen Salloway, Reisa A. Sperling, Murray A. Raskind, Marwan N. Sabbagh, Lawrence S. Honig, Anton P. Porsteinsson, Steven H. Ferris, David Weisman, Lynne Harris, Betty Diamond, A. Casher, V. Thomas, Daniel R. Rhodes, Celine Olivia, Andrea Years, Anthony Rosenzweig, Ronald Klein, Steven E. Arnold, V. Boruta, A Blue-Schaller, James McGowan, J. Wurziger, Özkan Yalkinoglu, J. Wurziger, Martina Kirsch, Christian Schindler, Arthur Spirling, M. Ohnesorge, Andreas Kluge, Martha McCartney, Thomas Stubbs, K. J. Sweeney, Keith A. Johnson, Roberto Santangelo, Benjamin K.P. Woo, Marcelo F. DiCarli, Steven Williams, J. M. Passler, D. Cheng, Wendy J. Ingram, S. Jutras, Moshe Shay, A. McGlew, S. Warner-Coviello, Rakesh Nandan, Paul Rees, Varun Mehra, Juliana Velosa Porras, S. Bryant, Caramés Bartolomé E, Carl K. Hoh, Jennifer M. Murphy, Salmaan Sharif, Monte S. Buchsbaum, K E Kortman, István Kovács, Neelee Chini, Lisa Brown, Gus Alva, Ajjai Alva, J. Kellogg, Mathilde Lykke, Markus Rabe, B. Shih, Joseph C. Wu, Carl K. Hoh, Monte S. Buchsbaum, Pierre N. Tariot, R. Yaari, Scott A. Small, M. Chavira, Eric M. Reiman, H. Brand, Lisa Cooper, W. Dennis-Busier, Dan Bandy, James D. Seward